|
Market Closed -
Nasdaq
16:00:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 468.11 USD | +0.62% |
|
-2.17% | +43.02% |
| 11-11 | Amgen's Sjogren's drug cuts disease activity in trial | RE |
| 11-11 | Amgen Potential Autoimmune Drug Meets Primary Endpoint in Late-Stage Study | MT |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Static Chart
Select your edition
All financial news and data tailored to specific country editions
